From Name:
From Email:
To Name:
To Email:

Optional Message:

Dupixent appears to increase asthma control among poorly controlled patients

from Pharmacy Practice News

When added to standard therapies, dupilumab (Dupixent, Sanofi/Regeneron) reduced severe asthma exacerbations and improved lung function, according to a phase 3 study in a broad population of patients with uncontrolled, persistent asthma. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063